James E. Bradner

11.3k citations
64 papers · 4.7k · 2 hit papers · h-index 29

Impact in

  • Hematology top 1%
    • Multiple Myeloma Research and Treatments
    • Protein Degradation and Inhibitors
    • Histone Deacetylase Inhibitors Research
    • Ubiquitin and proteasome pathways
    • Epigenetics and DNA Methylation
    • Cancer-related gene regulation

Papers in

    • Protein Degradation and Inhibitors 32
    • Histone Deacetylase Inhibitors Research 23
    • Ubiquitin and proteasome pathways 12
    • Epigenetics and DNA Methylation 11
    • Cancer-related gene regulation 8
    • Multiple Myeloma Research and Treatments 16
    • Chronic Myeloid Leukemia Treatments 6

James E. Bradner

62 papers receiving 4.6k citations

James E. Bradner's Hit Papers

Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma 2012 · 501 citations
5010+7+14Years since publication200400600

Peers

James E. Bradner
Comparison fields: 5 of 105
  • Hematology 699
  • Molecular Biology 3.6k
  • Oncology 1.2k
  • Geriatrics and Gerontology 79
  • Physiology 115
Replace Mariateresa Fulciniti with:
Mariateresa Fulciniti United States
Yosef Landesman United States
Arnaud Jacquel France
J. David Becherer United States
Alejandro Villagra United States
Kimal Rajapakshe United States
Chia‐Hsin Chan United States
Joseph M. Amann United States
Dongfeng Qu United States
James E. Bradner relative to Mariateresa Fulciniti United States Mariateresa Fulciniti's profile →
Citations per field
00.5×1.7×
Mariateresa Fulciniti · 1×
Citations per year

Countries citing papers authored by James E. Bradner

Since Specialization
Citations

This map shows the geographic impact of James E. Bradner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Bradner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Bradner more than expected).

Fields of papers citing papers by James E. Bradner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Bradner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Bradner. The network helps show where James E. Bradner may publish in the future.

Co-authors

The 25 scholars most cited alongside James E. Bradner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James E. Bradner Line = papers co-authored together James E. Bradner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90
Hit paper breakdown →
2005666
2
Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
Hit paper breakdown →
2012501
3 2016352
4 2014327
5 2013316
6 2015228
7 2011223
8 2016177
9 2013164
10 2008164
11 2011163
12 2018157
13 2013147
14
Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
1999118
15 201797
16 201185
17 201879
18 201678
19 200975
20 201671

About James E. Bradner

James E. Bradner is a scholar working on Molecular Biology, Hematology, Oncology, Genetics and Immunology, having authored 64 papers that have together received 4.7k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (32 papers), Histone Deacetylase Inhibitors Research (23 papers), Multiple Myeloma Research and Treatments (16 papers), Ubiquitin and proteasome pathways (12 papers), Epigenetics and DNA Methylation (11 papers), Peptidase Inhibition and Analysis (11 papers), Cancer-related gene regulation (8 papers) and Chronic Myeloid Leukemia Treatments (6 papers). The work is most often cited by research in Hematology (699 citations), Molecular Biology (3.6k citations), Oncology (1.2k citations), Geriatrics and Gerontology (79 citations) and Physiology (115 citations). James E. Bradner has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Kapil N. Bhalla, Jun Qi, Warren Fiskus, Peter Atadja, Fei Guo, Sandhya Boyapalle, Edward Seto, Michael Pranpat, Sandhya Kumaraswamy and Kathy Rocha. Their work appears in journals such as Blood, Cancer Research, Genome Research, Cancer Cell and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact